Differential cardiovascular profiles of sodium-glucose cotransporter 2 inhibitors: critical evaluation of empagliflozin.
about
Differential cardiovascular profiles of sodium-glucose cotransporter 2 inhibitors: critical evaluation of empagliflozin.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Differential cardiovascular pr ...... l evaluation of empagliflozin.
@en
Differential cardiovascular pr ...... l evaluation of empagliflozin.
@nl
type
label
Differential cardiovascular pr ...... l evaluation of empagliflozin.
@en
Differential cardiovascular pr ...... l evaluation of empagliflozin.
@nl
prefLabel
Differential cardiovascular pr ...... l evaluation of empagliflozin.
@en
Differential cardiovascular pr ...... l evaluation of empagliflozin.
@nl
P2093
P2860
P356
P1476
Differential cardiovascular pr ...... l evaluation of empagliflozin.
@en
P2093
Robert Chilton
Ruben Rodriguez
Saurabh Sanon
Shalin Patel
Son V Pham
Vani P Sanon
P2860
P304
P356
10.2147/TCRM.S97619
P577
2017-05-03T00:00:00Z